ASTS

AST SpaceMobile, Inc.

49
Fundamentals66/ 100
Valuation50/ 100
Upside potential65/ 100
Risk potential46/ 100

ASTS lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow, though they disagree widely on how much.

QTEX

QTREX Quantum Ltd.

There isn't enough reported data to score QTEX yet.

ASTS Fundamentals

MetricStatus
Healthy
Weak
Weak
Unavailable

ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.

QTEX Fundamentals

MetricStatus
Unavailable
Under pressure
Unavailable
Unavailable

QTEX's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.

ASTS PE Valuation

ASTS has no meaningful PE right now: it lost money over the past year.

QTEX PE Valuation

QTEX has no meaningful PE right now: it lost money over the past year.

ASTS Forward outlook

MetricOutlook
--
Losses growing
Strong growth
--
Limited
Low

Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.

QTEX Forward outlook

There aren't enough analyst estimates for QTEX to show an outlook.

ASTS Risk to reward

ScenarioChangePrice
Upside+86%$64.16
Downside-46%$18.77

Calculated from the latest close: $34.50 on Nov 12.

There is not enough scenario data to compare ASTS and QTEX's risk to reward.

QTEX Risk to reward

ScenarioChangePrice
UpsideUnknownโ€”
DownsideUnknownโ€”

Calculated from the latest close: $1.19 on Nov 12.

There is not enough scenario data to compare ASTS and QTEX's risk to reward.

ASTS Earnings Per Share

Q1 2024: $-0.98Q2 2024: $-1.25Q3 2024: $-2.12Q4 2024: $-1.95Q1 2025: $-1.99Q2 2025: $-1.89Q3 2025: $-1.24Q4 2025: $-1.34Q1 2026: $-1.80Q2 2026: $-2.16Q3 2026: $-2.15
Q1 2024: $-0.98Q2 2024: $-1.25Q3 2024: $-2.12Q4 2024: $-1.95Q1 2025: $-1.99Q2 2025: $-1.89Q3 2025: $-1.24Q4 2025: $-1.34Q1 2026: $-1.80Q2 2026: $-2.16Q3 2026: $-2.15
QuarterTTM EPSYoY
Q3 2026-$2.15-$0.91
Q2 2026-$2.16-$0.27
Q1 2026-$1.80+$0.19
Q4 2025-$1.34+$0.61
Q3 2025-$1.24+$0.88
Q2 2025-$1.89-$0.64
Q1 2025-$1.99-$1.01
Q4 2022-$0.58-$0.21

ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.

QTEX Earnings Per Share

Q4 2024: $-0.60Q2 2025: $-0.46Q4 2025: $-0.45
Q4 2024: $-0.60Q2 2025: $-0.46Q4 2025: $-0.45
QuarterTTM EPSYoY
Q4 2025-$0.45+$0.15

QTEX and ASTS do not have enough comparable growth data to identify a winner.

ASTS Quarterly Revenue

Q4 2023: $0Q1 2024: $500,000Q2 2024: $900,000Q3 2024: $1MQ4 2024: $2MQ1 2025: $718,000Q2 2025: $1MQ3 2025: $15MQ4 2025: $54MQ1 2026: $15MQ2 2026: $32MQ3 2026: $42M
Q4 2023: $0Q1 2024: $500,000Q2 2024: $900,000Q3 2024: $1MQ4 2024: $2MQ1 2025: $718,000Q2 2025: $1MQ3 2025: $15MQ4 2025: $54MQ1 2026: $15MQ2 2026: $32MQ3 2026: $42M
QuarterRevenueYoY
Q3 2026$42.3M+187%
Q2 2026$31.5M+2627%
Q1 2026$14.7M+1952%
Q4 2025$54.3M+2731%
Q3 2025$14.7M+1240%
Q2 2025$1.2M+28%
Q1 2025$718K+44%
Q3 2022$4.2M+70%

ASTS's revenue has grown year over year for 11 quarters in a row: $42M last quarter, up 187% from the same quarter a year ago.

QTEX Quarterly Revenue

Q4 2022: --Q2 2024: --Q4 2024: --Q2 2025: $289,000Q4 2025: $0
Q4 2022: --Q2 2024: --Q4 2024: --Q2 2025: $289,000Q4 2025: $0

QTEX and ASTS do not have enough comparable growth data to identify a winner.

ASTS Free Cash Flow

Q4 2023: โˆ’$47MQ1 2024: โˆ’$88MQ2 2024: โˆ’$38MQ3 2024: โˆ’$64MQ4 2024: โˆ’$110MQ1 2025: โˆ’$149MQ2 2025: โˆ’$354MQ3 2025: โˆ’$303MQ4 2025: โˆ’$331MQ1 2026: โˆ’$310MQ2 2026: โˆ’$695MQ3 2026: โˆ’$464M
Q4 2023: โˆ’$47MQ1 2024: โˆ’$88MQ2 2024: โˆ’$38MQ3 2024: โˆ’$64MQ4 2024: โˆ’$110MQ1 2025: โˆ’$149MQ2 2025: โˆ’$354MQ3 2025: โˆ’$303MQ4 2025: โˆ’$331MQ1 2026: โˆ’$310MQ2 2026: โˆ’$695MQ3 2026: โˆ’$464M
QuarterFree cash flowYoY
Q3 2026-$464.2M-$161.4M
Q2 2026-$694.8M-$341.1M
Q1 2026-$309.7M-$160.7M
Q4 2025-$330.7M-$220.3M
Q3 2025-$302.9M-$239.1M
Q2 2025-$353.6M-$315.3M
Q1 2025-$149M-$61.3M
Q4 2024-$110.5M-$63.2M

ASTS has burned cash in almost every quarter: โˆ’$1.8B over the past year, against โˆ’$916M the year before.

QTEX Free Cash Flow

Q4 2022: โˆ’$6MQ2 2024: โˆ’$5MQ4 2024: โˆ’$5MQ2 2025: โˆ’$5MQ4 2025: โˆ’$5M
Q4 2022: โˆ’$6MQ2 2024: โˆ’$5MQ4 2024: โˆ’$5MQ2 2025: โˆ’$5MQ4 2025: โˆ’$5M
QuarterFree cash flowYoY
Q4 2025-$4.8M-$97K
Q2 2025-$5.2M-$329K

QTEX and ASTS do not have enough comparable growth data to identify a winner.

ASTS Total Shares

Q4 2023: 90MQ1 2024: 121MQ2 2024: 141MQ3 2024: 156MQ4 2024: 199MQ1 2025: 224MQ2 2025: 242MQ3 2025: 273MQ4 2025: 256MQ1 2026: 291MQ2 2026: 299MQ3 2026: 300M
Q4 2023: 90MQ1 2024: 121MQ2 2024: 141MQ3 2024: 156MQ4 2024: 199MQ1 2025: 224MQ2 2025: 242MQ3 2025: 273MQ4 2025: 256MQ1 2026: 291MQ2 2026: 299MQ3 2026: 300M
PeriodChange %Net change
Quarterly+0.4%+1.1M shares
1 year+10%+27.3M shares
3 years+235%+211M shares
5 years+480%+248M shares
Available history+944%+271M shares

ASTS has 300M diluted shares, up 10% from a year ago.

QTEX Total Shares

Q4 2022: 11MQ2 2024: 17MQ2 2025: 27MQ4 2025: 30M
Q4 2022: 11MQ2 2024: 17MQ2 2025: 27MQ4 2025: 30M
PeriodChange %Net change
Quarterly+11%+2.8M shares

ASTS Net Leverage

ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

QTEX Net Leverage

QTEX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

ASTS Weekly Momentum

MetricValueStatus
RSI34.1Neutral
Stochastic11.9Oversold

ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).

QTEX Weekly Momentum

MetricValueStatus
RSI51.1Neutral
Stochastic42.4Neutral

QTEX's weekly RSI is 51 (neutral) and its Stochastic is 42 (neutral).

ASTS PE vs Technology Sector

ASTS has no meaningful PE right now: it lost money over the past year.

QTEX PE vs Technology Sector

QTEX has no meaningful PE right now: it lost money over the past year.

ASTS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$44.923% below
20 week MA$57.140% below
50 week MA$75.554% below
100 week MA$57.840% below
200 week MA$33.62.8% above

ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.

QTEX Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$1.265.6% below
20 week MA$1.135.3% above
50 week MA$0.9821% above
100 week MA$0.9624% above
200 week MA$1.180.8% above

QTEX has the edge over ASTS on trend strength, trading above more of its moving averages.

ASTS Yearly ROI

YearStart priceEnd priceROI
2020$9.87$13.4+36%
2021$13.4$8.71-35%
2022$8.71$3.97-54%
2023$3.97$6.03+52%
2024$6.03$22.9+280%
2025$22.9$72.0+214%
2026 YTD$72.0$34.5-52%

ASTS's yearly returns have swung widely, from +280% in 2024 to โˆ’54% in 2022. It's down 52% so far in 2026.

QTEX Yearly ROI

YearStart priceEnd priceROI
2021$4.77$3.66-23%
2022$3.66$1.32-64%
2023$1.32$1.06-20%
2024$1.06$1.060%
2025$1.06$0.97-8.5%
2026 YTD$0.97$1.19+23%

QTEX has the edge over ASTS on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key